淀粉样变性周围神经病变难治性疼痛的管理
本文报告一例继发于淀粉样神经病的双上下肢及躯干严重难治性神经病理性疼痛患者,多种神经病理性及阿片类药物试验不良反应明显且缓解有限。Scrambler疗法带来短期但不持续获益,脊髓电刺激因症状弥散被认为不理想,最终植入鞘内药物输注系统输注氢吗啡酮,所有受累区域疼痛显著减轻且不良反应改善,患者生活质量大幅提高。
要点
- 淀粉样神经病理性疼痛常难治,常规药物不良反应明显且缓解有限。
- Scrambler疗法可获得短期但不持续的镇痛获益。
- 症状弥散时脊髓电刺激可能不是理想选择。
核心结论
- 淀粉样神经病理性疼痛常难以治疗,鞘内药物输注系统可带来显著镇痛获益并改善生活质量。
研究设计与样本
- 个案报告:一例继发于淀粉样神经病的双上下肢及躯干严重难治性神经病理性疼痛男性患者。
主要发现
- 多种神经病理性及阿片类药物试验不良反应明显且缓解有限。
- Scrambler疗法带来短期但不持续的获益。
- 脊髓电刺激因症状弥散被认为不理想。
- 鞘内氢吗啡酮输注使所有受累区域疼痛显著减轻且不良反应改善。
- 尽管系统性淀粉样变性进展,患者生活质量仍大幅提高。
临床怎么用
- 对淀粉样神经病理性难治性疼痛,可考虑鞘内药物输注系统作为镇痛选择。
局限性
- 本文为个案报告,结论需更多研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic amyloidosis is a disease that often involves multiple organ systems, including the peripheral nervous system. Patients may present with severe, refractory neuropathic pain; however, the optimal treatment approach for pain for these patients remains unclear. CASE REPORT: A man with severe, refractory neuropathic pain in his bilateral upper and lower extremities and the trunk secondary to amyloid neuropathy is presented. Multiple medication trials, including neuropathic and opioid agents, produced considerable adverse effects and minimal relief. Scrambler therapy, a novel electrical stimulation modality, was used and was associated with substantial short-term but nonsustained benefit. Spinal cord stimulation was considered, but given his diffuse symptoms, it was deemed a less-than-optimal approach. Ultimately, an intrathecal drug delivery system was placed with infusion of hydromorphone, resulting in substantial pain reduction in all involved areas and with an improved adverse effect profile. This intervention resulted in immense improvement in the patient's quality of life, despite progression of his systemic amyloidosis. CONCLUSIONS: Severe pain in the setting of amyloid neuropathy is often difficult to treat. To our knowledge, this represents the first report of Scrambler therapy or an implanted intrathecal drug delivery system used for a patient with refractory amyloidosis-related neuropathic pain, resulting in substantial analgesic benefit and improved quality of life.
引用
- Warner NS, Watson JC, Bendel MA, et al. Refractory Pain Management in Amyloid-Associated Peripheral Neuropathy. Reg Anesth Pain Med. 2018. PMID: 29346227. doi:10.1097/AAP.0000000000000733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。